BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 7679709)

  • 1. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
    Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
    J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
    Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
    J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.
    Bertoletti A; Ferrari C; Fiaccadori F; Penna A; Margolskee R; Schlicht HJ; Fowler P; Guilhot S; Chisari FV
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10445-9. PubMed ID: 1660137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis.
    Rehermann B; Fowler P; Sidney J; Person J; Redeker A; Brown M; Moss B; Sette A; Chisari FV
    J Exp Med; 1995 Mar; 181(3):1047-58. PubMed ID: 7532675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.
    Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C
    J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals.
    Khakoo SI; Ling R; Scott I; Dodi AI; Harrison TJ; Dusheiko GM; Madrigal JA
    Gut; 2000 Jul; 47(1):137-43. PubMed ID: 10861276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes.
    Kuhröber A; Wild J; Pudollek HP; Chisari FV; Reimann J
    Int Immunol; 1997 Aug; 9(8):1203-12. PubMed ID: 9263018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of HLA-A*0201-restricted CD8+ T-cell epitope C₆₄₋₇₂ from hepatitis B virus core protein.
    Liu Q; Zheng Y; Yu Y; Tan Q; Huang X
    Int Immunopharmacol; 2012 Jun; 13(2):141-7. PubMed ID: 22480777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes.
    Sijts AJ; Ruppert T; Rehermann B; Schmidt M; Koszinowski U; Kloetzel PM
    J Exp Med; 2000 Feb; 191(3):503-14. PubMed ID: 10662796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes.
    Tsai SL; Chen MH; Yeh CT; Chu CM; Lin AN; Chiou FH; Chang TH; Liaw YF
    J Clin Invest; 1996 Jan; 97(2):577-84. PubMed ID: 8567982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus (HBV)-specific cytotoxic T-cell response in humans: production of target cells by stable expression of HBV-encoded proteins in immortalized human B-cell lines.
    Guilhot S; Fowler P; Portillo G; Margolskee RF; Ferrari C; Bertoletti A; Chisari FV
    J Virol; 1992 May; 66(5):2670-8. PubMed ID: 1313893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
    Chung MK; Yoon H; Min SS; Lee HG; Kim YJ; Lee TG; Lim JS; Kim CM; Park SN
    J Immunother; 1999 Jul; 22(4):279-87. PubMed ID: 10404429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus core antigen epitopes presented by HLA-A2 single-chain trimers induce functional epitope-specific CD8+ T-cell responses in HLA-A2.1/Kb transgenic mice.
    Zhang Y; Li S; Shan M; Pan X; Zhuang K; He L; Gould K; Tien P
    Immunology; 2007 May; 121(1):105-12. PubMed ID: 17244158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with the HBV core 18-27 epitope elicits CTL responses in humans expressing different HLA-A2 supertype molecules.
    Livingston BD; Crimi C; Fikes J; Chesnut RW; Sidney J; Sette A
    Hum Immunol; 1999 Nov; 60(11):1013-7. PubMed ID: 10599997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the Ld-restricted cytotoxic T-lymphocyte epitope in the mouse hepatitis virus nucleocapsid protein.
    Bergmann C; McMillan M; Stohlman S
    J Virol; 1993 Dec; 67(12):7041-9. PubMed ID: 7693965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein.
    Bertoletti A; Chisari FV; Penna A; Guilhot S; Galati L; Missale G; Fowler P; Schlicht HJ; Vitiello A; Chesnut RC
    J Virol; 1993 Apr; 67(4):2376-80. PubMed ID: 7680391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.
    Thimme R; Chang KM; Pemberton J; Sette A; Chisari FV
    J Virol; 2001 Apr; 75(8):3984-7. PubMed ID: 11264388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTL escape mutations of core protein are more frequent in strains of HBeAg negative patients with low levels of HBV DNA.
    Sendi H; Mehrab-Mohseni M; Shahraz S; Norder H; Alavian SM; Noorinayer B; Zali MR; Pumpens P; Bonkovsky HL; Magnius LO
    J Clin Virol; 2009 Nov; 46(3):259-64. PubMed ID: 19748824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.